British Columbia Cancer Agency: Breast Neoplasms trials

The registry lists 14 Breast Neoplasms studies with British Columbia Cancer Agency as lead sponsor. 3 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 2 5Phase 3 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast TumorsNot yet recruitingNCT06937281Not applicable
• Genomic and Transcriptomic Predictors of Sequential SG Sensitivity After T-DXd in ER+/HER2-Low Metastatic Breast CancerRecruitingNCT06665178Phase 2
• Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible SensitivityRecruitingNCT04273061Phase 2
• Limited Adjuvant Endocrine Therapy for Low Risk Breast CancerActive, not recruitingNCT03917082Phase 2
• Informative Tools to Optimize Neoadjuvant Therapy in ER Positive, HER2 Negative Breast CancersStatus unknownNCT03790813Not applicable
• Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant ChemotherapyStatus unknownNCT03566394Phase 2/3
• (Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast CancerStatus unknownNCT02627703
• Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed ImplantActive, not recruitingNCT02297672Not applicable
• Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast CancerWithdrawnNCT01814865Phase 2
• Pilot Study of Partial Breast Irradiation Utilizing Permanent Breast Seed Implant to Treat Breast CancerStatus unknownNCT01191164Not applicable
• A Trial Testing Professional and Peer-led Support Online Support Groups for Young Canadian Breast Cancer SurvivorsStatus unknownNCT01089699Early Phase 1
• PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast CancerTerminatedNCT00816582Not applicable
• Do Skin Markings Reflect the Location of the Surgical Cavity During Daily Radiotherapy Treatment?CompletedNCT00578747
• The Use of Silver Leaf Dressing in the Prevention of Radiotherapy Induced Skin ReactionsCompletedNCT00207324Phase 3